Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation

Am J Hematol. 2022 Jun 1;97(6):E220-E223. doi: 10.1002/ajh.26540. Epub 2022 Mar 28.

Authors

Elizabeth F Krakow^{1

2}, Roland B Walter^{1

3}, Julia M Nathe¹, Tess Perez¹, Ali Ahmed¹, Nayak Polissar⁴, Ljubomir Miljacic⁴, Anna B Halpern^{1

3}, Mary E D Flowers^{1

2}, Eli Estey^{1

3}

Affiliations

¹ Clinical Research Division of the Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Division of Medical Oncology, University of Washington, Seattle, WA, USA.
³ Division of Hematology, University of Washington, Seattle, WA, USA.
⁴ The Mountain-Whisper-Light: Statistics & Data Science, Seattle, WA, USA.

PMID: 35303371
DOI: 10.1002/ajh.26540

No abstract available

Publication types

Letter

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / drug therapy
Recurrence
Transplantation Conditioning